Volume 7, Issue 8

COVID-19: The Morbidity/Mortality Risk

In this issue:

Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for PWLH to get vaccinated and boosted? Is breakthrough COVID-19 infection more likely to occur among PLWH? What about “long COVID” (PASC)?

Join Clinical Research Nurse Diane Kanjilal, manager of the Infectious Disease Clinical Research Unit at Massachusetts General Hospital, as we discuss these questions in this eHIV Review podcast.

Learning objectives:

  • Discuss recent research data evaluating COVID-19 mortality risk and vaccine immunogenicity in people living with HIV.
  • Describe potential implications long COVID (PASC) may have on PLWH and the general public.

Author:

Diane Kanjilal, FNP-BC
Diane Kanjilal, FNP-BC
Family Nurse Practitioner Clinical Research Nurse Manager, Infectious Diseases Clinical Research Unit Massachusetts General Hospital Boston, MA

Program Directors:

Justin Alves, RN, ACRN, CARN

Nurse Educator – Office Based Addiction Treatment, Training and Technical Assistance Program
Boston Medical Center
Boston, Massachusetts
(he/him/his)

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: May 26, 2022
Expiration date: May 25, 2024